Understanding the NASH Market Landscape

Tina Healy, MSci, is the Vice President of Disease Analysis and Intelligence at GlobalData. Prior to this role, Tina was a Senior Director and managed the Immunology and Neurology market analysis and forecasts portfolios and GlobalData’s syndicated Competitive Intelligence (CI) portfolio. Tina has over nine years’ experience in pharmaceutical market intelligence, three years’ experience in drug discovery, and a proven track record of disease and competitive analysis. Prior to her roles at GlobalData, Tina was an Engagement Manager with consulting firm Lifescience Dynamics, covering CI deep-dive and monitoring projects, MR and MA projects. Prior to joining Lifescience Dynamics, Tina was the Director for Immunology at GlobalData, where she managed the production of syndicated reports, product forecasts, and analyses in autoimmune diseases. Tina has also held several Analyst roles at GlobalData and at Datamonitor, covering Immunology-Inflammation, where she authored numerous in-depth analyses of products and companies, bespoke client deliverables, and produced sales- and patient-based indication-specific forecasts. Before joining Datamonitor, Tina worked as a research scientist within GSK’s drug discovery medicinal chemistry unit. Prior to that role, she worked within the early drug development unit at Evotec, a drug-discovery alliance and development partnership company. Tina holds a Master’s degree in Medicinal Chemistry from University College London.

Lakshmi Dharmarajan, PhD, PPM, is the Associate Director of the Immunology team at GlobalData in Boston, where she incorporates strategic and business insights to conduct disease-specific market research and also provides commentary about the latest developments in the life sciences industry. She received her Ph.D. in an interdisciplinary Biochemistry program from Virginia Tech, VA. As part of her dissertation, Lakshmi completed a research fellowship investigating the structure and function of enzymes regulating glucose metabolism in humans. Following up on her desire to transition towards the business side of life sciences, she subsequently obtained a professional master’s (PPM) degree in Bioscience Management from the Keck Graduate Institute, CA. During this time, she worked on short-term projects with companies like Eli Lilly, GE Healthcare and Veracyte and also with academic technology transfer offices. Prior to this, Lakshmi obtained a BS in Biotechnology from Haldia Institute of Technology in India.